≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other mycoses, not elsewhere classified/unspecified

Endpoint Browser PheWeb

AB1_MYSOSIS_NOS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B48, B49
  • Hospital discharge: ICD-9 — 11[7-9]
  • Hospital discharge: ICD-8 — 117
  • Hospital discharge: excluded ICD-9 — 117[1-5]
  • Hospital discharge: excluded ICD-8 — 117[1-3]
  • Cause of death: ICD-10 — B48, B49
  • Cause of death: ICD-9 — 11[7-9]
  • Cause of death: ICD-8 — 117
  • Cause of death: excluded ICD-9 — 117[1-5]
  • Cause of death: excluded ICD-8 — 117[1-3]

2 out of 7 registries used, show all original rules.

179

4. Check minimum number of events

None

179

5. Include endpoints

None

179

6. Filter based on genotype QC (FinnGen only)

139

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1022 457 554
Only index persons 724 330 394
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.02
Only index persons 0.01 0.01 0.02
Median age at first event (years)
Whole population 56.38 57.52 55.64
Only index persons 53.71 56.31 51.53

-FinnGen-

Key figures

All Female Male
Number of individuals 139 62 77
Unadjusted period prevalence (%) 0.03 0.02 0.04
Median age at first event (years) 64.28 61.05 66.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
147
Matched controls
1470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B49
ICD-10 Finland
Unspecified mycosis
+∞
53.4
48
*
B48.5
ICD-10 Finland
Pneumocystosis
+∞
32.5
30
*
B48.8
ICD-10 Finland
Other specified mycoses
391.6
32.2
31
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
28.2
36
45
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.3
24.9
34
46
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
24.7
23
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.3
23.0
78
257
B48.7
ICD-10 Finland
Opportunistic mycoses
+∞
22.5
21
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
16.9
52
153
GD1AD
NOMESCO Finland
Thorax CT examination
7.1
16.2
27
45
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.4
15.9
30
57
J02AC03
ATC
voriconazole; systemic
47.7
14.4
17
*
TGC00
NOMESCO Finland
Bronchial lavation
13.4
13.9
24
21
127
Kela drug reimbursment
Transplant complication
38.1
13.8
17
5
XW000
NOMESCO Finland
Bone marrow biopsy
12.2
12.8
23
22
L04AA06
ATC
mycophenolic acid; systemic
27.2
12.8
17
7
WX892
NOMESCO Finland
Monitored bed care
5.5
12.2
26
55
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.0
12.0
23
44
J01MA14
ATC
moxifloxacin; systemic
4.7
11.7
31
79
JN4AD
NOMESCO Finland
Body CT examination
4.3
11.6
36
104
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
11.5
96
524
A41.9
ICD-10 Finland
Sepsis, unspecified
9.5
11.3
23
28
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.5
11.3
32
86
R50.9
ICD-10 Finland
Fever, unspecified
3.8
11.3
43
144
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
10.7
21
41
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.4
10.6
31
85
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
10.0
33
99
H02AB06
ATC
prednisolone; systemic
3.0
9.6
89
497
A04AA01
ATC
ondansetron; systemic, rectal
4.4
9.4
26
68
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.6
9.1
18
21
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
9.1
26
70
L04AD02
ATC
tacrolimus; systemic
25.9
9.1
12
5
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
8.9
35
118
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
21.6
8.6
12
6
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.1
8.6
26
73
L04AX01
ATC
azathioprine; systemic
10.4
8.5
16
17
B37.7
ICD-10 Finland
Candidal sepsis
+∞
8.4
8
*
11799
ICD-8 Finland
Other systemic mycosis, Unspecified
+∞
8.4
8
*
B03XA02
ATC
darbepoetin alfa; parenteral
15.7
8.4
13
9
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.1
8.4
20
32
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
8.2
29
91
A41.8
ICD-10 Finland
Other specified sepsis
14.1
8.0
13
10
ZX120
NOMESCO Finland
Intravenous
3.9
8.0
26
77
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
7.9
22
58
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
12.8
7.7
13
11
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
7.7
21
54
L03AA02
ATC
filgrastim; parenteral
7.2
7.7
18
28
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
7.3
55
268
J01MA12
ATC
levofloxacin; systemic
2.9
7.2
42
178
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
12.9
7.2
12
10
JN4BD
NOMESCO Finland
Extensive body CT
3.3
7.1
30
105
C03CA01
ATC
furosemide; systemic
2.6
7.0
57
288
A07AA02
ATC
nystatin; oral
6.1
6.9
18
33
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.7
6.8
10
6
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
42.0
6.8
8
*
Z94.0
ICD-10 Finland
Kidney transplant status
42.0
6.8
8
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
3.5
6.4
24
78
XG410
NOMESCO Finland
Flow-volume spirometry
6.6
6.2
15
25
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.9
6.1
19
54
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
7.8
6.1
13
18
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.9
6.0
14
22

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
75
158
8.65
38.67
4.3
1.4
—
—
—
0
0
60
156
5.81
23.42
23.8
8.6
7.42
7.42
ph
0.16
35
85
58
156
5.49
21.57
24.3
8.6
1.48
0.69
mmol/l
0.56
50
132
25
31
9.51
19.38
1.9
1.2
—
—
—
0
0
36
70
6.49
18.80
11.1
4.3
—
—
—
0
0
47
118
5.39
18.65
8.2
2.1
7.40
10.33
g/l
4.38
47
108
35
67
6.54
18.55
2.4
1.7
1.56
1.57
g/l
0.02
27
61
86
369
4.21
16.69
20.1
4.7
—
—
—
0
0
47
129
4.89
16.62
4.5
3.0
73.54
70.83
e9/l
0.14
38
86
59
195
4.38
16.42
5.2
1.8
—
—
—
0
0
27
23
14.10
15.85
2.7
1.9
—
—
—
0
0
27
23
14.10
15.85
2.7
1.9
—
—
—
0
0
27
23
14.10
15.85
2.7
1.9
—
—
—
0
0
27
23
14.10
15.85
2.7
1.9
—
—
—
0
0
55
191
4.00
14.00
22.8
5.8
1.07
1.04
mmol/l
0.37
55
179
43
129
4.30
13.32
18.2
4.4
2.21
1.97
mmol/l
0.11
35
110
21
16
15.09
12.90
1.4
1.4
—
—
—
0
0
43
134
4.12
12.60
18.7
4.3
7.37
7.39
ph
0.89
29
76
24
47
5.91
12.21
1.8
1.3
—
—
—
0
0
87
439
3.41
12.04
25.9
6.1
—
—
—
0
0
39
119
4.10
11.69
9.6
5.5
0.96
0.77
%
0.32
28
43
16
8
22.20
11.41
3.1
1.8
—
—
—
0
0
14
5
30.67
10.94
55.4
30.8
8.26
5.10
ug/l
—
14
5
23
30
8.88
10.89
1.9
1.1
221.56
302.07
u/ml
0.29
16
14
59
249
3.29
10.74
2.4
2.0
—
—
—
0
0
110
671
3.54
10.58
21.2
6.5
0.04
0.04
e9/l
0.24
104
577
22
28
9.04
10.57
1.9
1.2
162.43
151.20
au/ml
—
7
10
36
112
3.93
10.43
9.4
5.6
1.00
0.37
%
1.44
26
39
109
669
3.43
10.21
21.3
6.5
0.60
0.58
e9/l
0.37
104
576
110
680
3.45
10.16
21.5
6.5
1.91
1.90
e9/l
0.01
104
602
111
695
3.44
9.92
23.1
6.7
0.17
0.19
e9/l
0.46
105
611
48
191
3.25
9.48
32.8
8.0
103.38
104.08
mmol/l
0.56
48
191
101
610
3.10
9.39
25.1
6.4
2.26
2.76
%
1.63
96
576
102
623
3.08
9.22
25.7
6.5
23.29
27.08
%
2.04
97
593
36
123
3.55
9.01
45.2
10.1
—
—
—
0
0
104
654
3.02
8.69
35.7
8.0
1.20
1.21
mmol/l
1.45
95
568
19
43
4.93
8.17
4.4
4.8
10.33
4.79
ratio
0.24
11
21
111
737
3.07
8.14
35.9
11.2
4.37
4.14
e9/l
0.39
106
643
44
181
3.04
8.08
1.4
1.4
420.00
384.21
titre
—
8
38
33
114
3.44
8.07
8.9
6.2
0.14
0.31
%
0.29
22
32
16
23
7.66
7.22
5.1
8.9
—
—
—
0
0
58
294
2.61
7.04
5.1
1.9
2.15
1.70
mg/l
0.33
52
231
68
372
2.54
7.04
6.0
3.2
—
—
—
0
0
12
11
11.75
6.93
1.2
1.1
—
—
—
0
0
18
45
4.42
6.85
3.6
1.9
25.56
24.09
mmol/l
0.62
18
45
20
55
4.05
6.74
8.1
2.1
1031.67
482.86
ug/l
0.27
20
50
51
249
2.61
6.63
7.6
3.8
340.18
300.36
ng/l
0.07
44
194
22
66
3.74
6.58
14.5
3.0
1.53
1.28
%
0.35
22
66
12
13
9.93
6.42
1.3
1.0
—
—
—
0
0
15
24
6.83
6.35
6.1
2.7
—
—
—
0
0
29
109
3.07
6.11
9.0
5.7
0.26
0.15
%
0.33
19
33
30
116
2.99
6.01
1.7
1.6
—
—
—
0
0
12
15
8.60
5.97
1.8
1.1
—
—
—
0
0
39
175
2.67
5.93
2.2
1.7
—
—
—
0
0
15
27
6.06
5.86
2.6
1.5
—
—
—
0
0
14
23
6.61
5.85
4.1
2.9
—
—
—
0
0
36
157
2.71
5.78
3.9
1.7
—
—
—
0
0
44
213
2.52
5.72
2.3
1.7
—
—
—
0
0
17
47
3.96
5.67
2.4
1.3
—
—
—
0
0
54
291
2.35
5.53
12.9
5.7
—
—
—
0
0
11
14
8.39
5.45
6.3
2.7
—
—
—
0
0
89
598
2.24
5.29
19.2
11.8
1.14
1.21
inr
1.02
84
485
16
36
4.86
5.24
1.3
1.1
—
—
—
0
0
30
128
2.69
4.99
2.7
1.4
—
—
—
0
0
19
63
3.32
4.88
16.0
3.0
0.52
0.60
%
0.40
19
63
12
21
6.12
4.87
1.1
1.0
—
—
—
0
0
41
207
2.36
4.79
1.8
1.7
1182.43
1201.61
nmol/l
0.04
34
155
88
604
2.14
4.77
9.8
2.8
—
—
estimate
—
0
0
7
5
14.59
4.62
1.0
1.0
—
—
—
0
0
16
49
3.54
4.62
1.3
1.2
—
—
—
0
0
8
8
10.48
4.58
1.0
1.3
—
—
—
0
0
12
23
5.58
4.57
3.8
2.4
—
—
—
0
0
68
430
2.08
4.51
10.4
2.5
—
—
—
0
0
19
67
3.11
4.42
7.2
3.5
—
—
—
0
0
9
13
7.29
4.23
1.2
1.0
—
—
—
0
0
16
53
3.27
4.11
12.3
1.6
1.82
1.34
mg/l
1.89
16
48
9
14
6.77
4.05
4.3
1.8
10.93
10.37
%
—
9
14
22
91
2.67
3.86
4.5
3.1
—
—
—
0
0
11
24
4.86
3.83
1.1
1.0
—
—
—
0
0
75
513
1.94
3.81
10.7
4.0
58.64
64.95
e6/l
0.05
60
359
12
29
4.41
3.80
6.5
1.6
—
—
—
0
0
6
5
12.42
3.79
1.8
1.2
—
—
—
0
0
6
5
12.42
3.79
2.8
1.0
—
—
—
0
0
7
9
8.10
3.60
1.1
1.4
—
—
—
0
0
62
406
1.91
3.52
17.7
4.6
7.39
7.40
ph
0.72
50
291
13
39
3.56
3.32
5.5
4.1
1.33
1.26
index
—
6
23
57
369
1.89
3.32
1.6
1.5
—
—
—
0
0
6
7
8.87
3.29
1.7
1.6
—
—
—
0
0
11
29
4.01
3.26
1.6
1.3
—
—
—
0
0
6
8
7.76
3.08
1.0
1.0
—
—
—
0
0
59
394
1.83
3.07
23.1
7.0
—
—
—
0
0
66
458
1.80
3.02
8.1
3.3
39.71
179.91
e6/l
0.48
54
347
5
5
10.28
3.00
8.0
1.4
1298.20
1073.20
u/ml
—
5
5
11
32
3.63
2.97
5.3
1.9
8.07
7.82
kpa
0.15
11
32
76
554
1.77
2.91
5.9
3.4
6.30
6.23
ph
0.21
45
307
7
13
5.59
2.90
3.3
4.3
—
—
—
0
0
77
564
1.77
2.90
3.1
2.0
94.55
97.71
pmol/l
0.23
51
294
23
112
2.25
2.86
1.8
2.0
—
—
—
0
0
39
233
1.92
2.84
7.8
3.3
2.83
2.26
e6/l
0.14
20
118
46
291
1.85
2.81
2.3
1.4
2.23
2.50
g/l
0.38
34
176
5
6
8.57
2.77
7.2
1.8
0.62
0.61
mmol/l
—
5
6
58
397
1.76
2.72
7.4
3.2
0.34
0.35
e6/l
0.00
48
287
15
61
2.62
2.72
2.2
2.3
—
—
—
0
0
8
20
4.17
2.61
1.6
1.4
—
—
—
0
0
29
162
1.98
2.55
5.1
3.0
4.89
5.86
e9/l
0.24
23
143
79
599
1.69
2.51
31.6
12.6
0.00
0.00
e9/l
0.50
68
492
89
697
1.70
2.50
6.7
3.7
0.00
11.44
estimate
0.50
16
142
7
17
4.27
2.39
2.1
2.6
12.03
10.12
mmol/l
—
7
17
89
704
1.67
2.34
6.8
3.7
0.00
0.00
estimate
-0.00
15
134
67
496
1.64
2.27
3.7
2.2
—
—
—
0
0
87
688
1.65
2.26
6.8
3.7
0.00
0.00
estimate
-0.00
16
140
37
234
1.78
2.22
1.3
1.3
24.99
25.07
iu/ml
—
10
71
7
20
3.62
2.08
1.4
1.2
—
—
—
0
0
20
105
2.05
2.08
12.6
4.2
154.10
78.71
ng/l
1.28
20
98
6
15
4.12
2.06
1.5
1.2
—
—
—
0
0
44
300
1.67
2.01
6.4
3.7
1.02
1.02
kg/l
0.25
35
203
5
11
4.66
1.95
1.6
1.5
4.08
4.17
mg/l
—
5
11
8
28
2.96
1.89
5.9
2.8
59.00
62.76
%
—
8
28
15
74
2.14
1.82
2.3
3.8
3.98
4.49
pmol/l
1.33
15
69
24
141
1.84
1.82
1.9
1.4
—
—
—
0
0
32
206
1.71
1.80
1.3
1.3
51.70
10.20
u/ml
—
8
77
5
13
3.94
1.73
3.2
5.5
2179.20
1338.46
mg
—
5
13
5
13
3.94
1.73
1.0
1.2
—
—
—
0
0
34
482
0.62
1.67
3.6
3.3
—
—
—
0
0
7
27
2.67
1.53
9.3
2.2
12.04
7.53
pmol/l
—
7
27
59
456
1.49
1.52
5.1
3.3
6.24
8.10
mmol/l
2.78
53
382
66
522
1.48
1.52
5.2
3.5
100.66
51.88
ng/l
0.28
53
369
10
46
2.26
1.43
1.0
1.2
—
—
titre
—
0
0
13
67
2.03
1.43
1.3
1.3
—
—
—
0
0
20
120
1.77
1.43
5.9
2.6
0.15
0.23
e6/l
0.38
20
115
56
436
1.46
1.37
5.5
4.2
15.19
9.58
mg/mmol
0.40
38
282
5
17
3.01
1.37
1.0
1.1
—
—
—
0
0
5
18
2.84
1.29
1.2
1.4
80.64
91.26
%
—
5
18
115
1037
1.50
1.21
75.1
20.8
14.42
13.67
%
4.59
115
1025
11
57
2.01
1.20
3.9
1.6
—
—
—
0
0
54
427
1.42
1.19
5.2
3.5
83.53
56.81
mg/l
0.34
37
286
5
20
2.55
1.16
3.0
2.1
—
—
—
0
0
11
58
1.97
1.15
2.2
2.4
—
—
—
0
0
63
523
1.36
1.01
5.8
3.5
0.00
0.02
estimate
0.50
15
121
8
45
1.82
0.86
1.5
1.2
—
—
—
0
0
23
311
0.69
0.85
2.2
3.3
0.74
0.80
ug/l
0.23
15
210
17
114
1.56
0.84
1.5
1.7
—
—
—
0
0
23
166
1.46
0.82
1.3
1.3
—
—
—
0
0
6
34
1.80
0.77
4.8
5.2
—
—
—
0
0
15
100
1.56
0.76
10.2
4.4
1.24
1.23
mmol/l
0.29
15
89
5
25
2.03
0.73
2.0
1.1
—
—
—
0
0
5
25
2.03
0.73
2.0
1.1
—
—
—
0
0
22
164
1.40
0.67
4.1
2.4
179.94
114.97
ug/g
0.41
17
126
119
1122
1.32
0.61
6.3
5.2
1.76
1.93
mu/l
1.18
112
1019
24
185
1.36
0.61
1.3
1.2
—
—
—
0
0
6
37
1.65
0.56
2.3
1.3
—
—
—
0
0
7
109
0.62
0.50
1.6
1.4
—
—
—
0
0
5
31
1.63
0.43
2.2
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
5.7
—
11.90
—
0
6
0
17
0.00
0.41
0.0
6.2
—
2.69
—
0
17
44
388
1.19
0.39
6.4
3.8
0.00
0.01
estimate
0.50
14
135
5
36
1.40
0.38
1.0
1.1
—
—
—
0
0
127
1229
1.25
0.35
72.5
16.1
31.90
23.47
mg/l
2.68
119
1012
6
44
1.38
0.35
4.2
1.3
—
—
—
0
0
6
45
1.35
0.34
4.2
1.3
—
—
—
0
0
6
46
1.32
0.33
4.2
1.3
—
—
—
0
0
6
46
1.32
0.33
4.2
1.3
—
—
—
0
0
6
47
1.29
0.32
4.2
1.3
—
—
—
0
0
7
54
1.31
0.31
1.3
1.1
—
—
—
0
0
130
1268
1.22
0.27
49.9
14.2
—
—
—
0
0
122
1186
1.17
0.25
6.5
5.2
6.31
6.00
mmol/l
1.02
115
1092
13
106
1.25
0.24
4.9
2.2
6.14
6.18
ph
—
7
71
0
10
0.00
0.21
0.0
2.0
—
2.88
—
0
10
0
10
0.00
0.21
0.0
2.1
—
1.93
—
0
10
119
1159
1.14
0.21
6.0
4.3
1.44
1.29
mmol/l
1.32
113
1065
0
14
0.00
0.20
0.0
1.0
—
285.13
—
0
8
5
67
0.74
0.17
1.2
1.1
—
—
—
0
0
9
80
1.13
0.15
2.1
1.2
—
33.90
—
0
5
18
160
1.14
0.15
1.8
1.3
—
—
—
0
0
16
141
1.15
0.14
2.4
2.4
11.26
13.78
nmol/l
0.55
16
128
52
496
1.07
0.12
4.2
5.7
3.18
2.35
ug/l
0.41
47
443
11
126
0.86
0.12
1.6
1.5
—
—
—
0
0
41
388
1.08
0.11
4.6
3.0
0.00
0.00
estimate
-0.00
12
114
30
318
0.93
0.09
1.2
1.3
1.21
1.42
u/ml
—
7
85
12
107
1.13
0.09
5.6
3.3
—
—
—
0
0
13
117
1.12
0.08
1.1
1.2
—
—
—
0
0
135
1340
1.09
0.05
86.7
24.7
92.04
91.20
fl
1.12
135
1325
135
1340
1.09
0.05
87.7
24.9
123.65
136.29
g/l
11.88
135
1323
135
1340
1.09
0.05
86.6
24.6
30.47
30.42
pg
0.11
135
1325
135
1340
1.09
0.05
95.1
25.2
37.10
40.57
%
8.60
135
1324
123
1220
1.05
0.03
6.1
5.9
2.54
2.68
mmol/l
1.25
115
1137
44
444
0.99
0.00
4.3
3.8
—
—
—
0
0
120
1205
0.98
0.00
5.4
5.1
1.35
1.44
mmol/l
1.20
114
1116
116
1162
0.99
0.00
7.6
6.5
41.08
39.72
mmol/mol
0.71
110
1084
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
34.44
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
37.78
—
0
5
121
1210
1.00
-0.00
5.9
5.2
4.38
4.57
mmol/l
1.40
115
1126
7
75
0.93
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
0.00
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
1543.17
—
0
6
0
6
0.00
-0.00
0.0
2.3
—
1.09
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_MYSOSIS_NOS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_MYSOSIS_NOS 4.838 [2.52, 9.31] < 0.001
Birth year 0.991 [0.98, 1.0] 0.043

During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 207 females with AB1_MYSOSIS_NOS died.

Males

Parameter HR [95% CI] p-value
AB1_MYSOSIS_NOS 4.742 [2.8, 8.04] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 94 out of 240 males with AB1_MYSOSIS_NOS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_MYSOSIS_NOS.

N-year risk Females Males
1 0.397% 1.023%
5 2.369% 4.884%
10 6.124% 12.269%
15 11.84% 22.656%
20 19.31% 36.018%

Relationships between endpoints

↥

Index endpoint: AB1_MYSOSIS_NOS – Other mycoses, not elsewhere classified/unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data